Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD), Estimated Glomerular Filtration Rate (eGFR), Neutrophil Gelatinase-associated Lipocalin (NGAL), Serum Creatinine (SCr), Urine Albumin (UAlb), Urine Creatinine (UCr)
Conditions
Keywords
Cardio-pulmonary bypass (CPB), renal replacement therapy (RRT), enzyme-linked immunosorbent assay (ELISA)
Brief summary
The study aims to recruit 156 (54 Acute Kidney Injury (AKI);102 non-AKI) patients undergoing Cardio pulmonary bypass (CPB) surgery, including those with Chronic Kidney Disease (CKD) and multiple co-morbidities. Urine and blood samples collected pre-operatively and then 0, 3, 6 and 18 hours post-CPB will be stored at -80oC until batch analysed for NGAL using the Abbott and BioPorto assays. AKI - defined as a ≥50% rise in serum creatinine (SCr) over baseline, or the requirement for renal replacement therapy (RRT). SCr will be measured pre-operatively (baseline), then 12 hourly for the first 48 hrs post-CPB and thereafter 24 hourly for 5 days. Clinical data collected will include patient demographics, co-morbidities, drug history, pre-operative renal function, surgery details (type, length, CPB time etc.), length of Intensive treatment unit and hospital stay and post-operative complications. Data will then be analysed comparing the two NGAL tests to find out which is superior, whether it is better to use blood or urine and to define optimal NGAL cut-offs and sample timing for predicting AKI. Both the Abbott and BioPorto assays will subject to a laboratory method evaluation prior to the analysis of any patient specimens in order to verify that their performance is acceptable and meets the manufacturer's claims. This will involve measuring the standard parameters used to assess laboratory assay performance e.g. imprecision (reproducibility), linearity, recovery and method comparison etc.
Interventions
PROCEDURECPB Surgery
Sponsors
The Royal Wolverhampton Hospitals NHS Trust
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult patients undergoing cardiac surgery, * Including patients with both normal renal function (eGFR \>60 mL/min) and pre-operative CKD (eGFR \< 60 mL/min), * Include patients with other existing co-morbidity (e.g. diabetes, vascular disease, hypothyroidism) plus those with risk factors of AKI e.g. nephrotoxic drugs.
Exclusion criteria
* Patients already on renal replacement therapy (RRT) * Post-renal transplant patients * Emergency surgery * Patients \<18 yrs of age * Pregnancy * Patients already involved with other on-going clinical studies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acute Kidney Injury (AKI) or requirement for RRT with 7 days of surgery. AKI is defined as a ≥50% rise in serum creatinine over baseline pre-operative levels (RIFLE stage R). | 24 months |
Secondary
| Measure | Time frame |
|---|---|
| Total stay in Intensive Treatment Unit (ITU) / High-Dependency Unit (HDU) | 24 months |
| Total length of hospital stay | 24 months |
| Mortality | 24 months |
Countries
United Kingdom
Outcome results
None listed